TXMD (TherapeuticsMD Corp) Prakiraan rega marang bathi

Logo korporat perusahaan TherapeuticsMD (TXMD)

TherapeuticsMD, Inc. (TXMD) price action is subject to the influence of high debt and delisting threats. Changes in the company's expected P/E highlight pressure from generics and the struggle for insurance coverage. A lack of new R&D developments limits growth, and the value of 0.00 shows the current magnitude of this multiple, helping to assess whether a systemic business decline is hidden behind the low price.

Rasio prakiraan rega marang bathi: therapeuticsmd.com (TXMD) kanggo 04.07.2022 - 16.11.2026

Ringkesan rincian data analitis therapeuticsmd.com (TXMD)

Ringkesan analitik perusahaan:TherapeuticsMD TXMD
Produk merek TherapeuticsMD, Inc.

Since TherapeuticsMD, Inc. (TXMD) has lost its pricing power by becoming a royalty recipient, the company's forward P/E ratio reflects only market expectations for passive cash flows. This ratio correlates current market capitalization with projected earnings for the following year, allowing investors to assess the premium paid for future income and determine the risk of a correction in the event of inflated market expectations.